CN103479967A - Medicine composition for treating rheumatism - Google Patents

Medicine composition for treating rheumatism Download PDF

Info

Publication number
CN103479967A
CN103479967A CN201310440361.3A CN201310440361A CN103479967A CN 103479967 A CN103479967 A CN 103479967A CN 201310440361 A CN201310440361 A CN 201310440361A CN 103479967 A CN103479967 A CN 103479967A
Authority
CN
China
Prior art keywords
parts
semen
herba
grams
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310440361.3A
Other languages
Chinese (zh)
Other versions
CN103479967B (en
Inventor
马秀连
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Municipal Hospital
Original Assignee
马秀连
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 马秀连 filed Critical 马秀连
Priority to CN201310440361.3A priority Critical patent/CN103479967B/en
Publication of CN103479967A publication Critical patent/CN103479967A/en
Application granted granted Critical
Publication of CN103479967B publication Critical patent/CN103479967B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine composition for treating rheumatism. The medicine composition is prepared from the following substances at weight ratio: green tea, acronychia pedunculata, Chinese rose flower, Chinese trumpet creeper, roughhair fig root, diversifolious patrinia root, alpine yarrow herb, mentha haplocalyx, amethyst, fiveleaf akebia fruit, saururus chinensis, spina gleditsiae, Chinese honey locust, figwort root, stalactitum, ophicslcite, semen lepidii, the fruit of Rangoon creeper, murraya paniculata, Peucedanum decursivum Maxim, centipeda, semen abutili, radix ampelopsis, veronicastrum herb, folium polygoni tinctrorii, fewflower lysionotus herb, eucommia bark, curcuma aromatica, long pepper, herba glechomae, cockscomb, longan pulp, folium turpiniae, garden balsam, concha haliotidis, Chinese wax gland peel, rhizoma bolbostemmae, folium microcotis, semen euryales, common coltsfoot flower, pine nodular branch, semen torreya, fructus polygoni orientalis, Chinese starjasmine stem, dayflower, rhizoma fagopyri dibotryis, valeriana jatamansi jones, chlorite schist, tuber fleeceflower stem and caulis bambusae in taeniam. The medicine composition has easily accessible raw materials, definite curative effect, high effective rate testified by experiments and low cost.

Description

A kind ofly treat rheumatismal pharmaceutical composition
Technical field
The present invention relates to the department of acupuncture and moxibustion field, relate in particular to a kind of rheumatismal pharmaceutical composition for the treatment of.
Background technology
Rheumatism refers to that take muscle, arthralgia is a main class disease.The connective tissue of major effect health may be that immune system injury causes.Rheumatism is due to the exopathogen such as wind, cold, wet, heat invasion and attack human body, the impatency meridians, QI-blood circulation is not smooth caused, the pain occurred with muscle, muscles and bones, joint, numbness, miserable, weighing, joint stuffiness, even the class disease that arthroncus, deformity etc. are main manifestations, also claim " arthromyodynia " or " numbness disease ".Be called " numbness " in Plain Questions of Huangdi's Internal Classic, the Han dynasty Zhang Zhongjing proposes the name of disease of " rheumatism " in " Medical Treasures of the Golden Chamber ", in this book " the wet abnormal pulse card of drinking of convulsion is controlled ", says: " patient's general aching on the body, heating, day are fed acute person, name rheumatism ".
Summary of the invention
The purpose of this invention is to provide a kind of rheumatismal pharmaceutical composition for the treatment of.
In order to realize purpose of the present invention, the invention provides a kind of rheumatismal pharmaceutical composition for the treatment of, it is to be made by the material of following weight proportioning: 25 parts of green tea, 8 parts of Lignum Dalbergiae Odoriferae, 13 parts of Flos Rosae Chinensiss, 15 parts of Flos Campsiss, 3 parts of Radix Fici Hirtaes, 8 parts of Radix Patriniae heterophyllaes, 2 parts of achillea millefoliums, 3 parts of Herba Menthaes, 7 parts of Fluoritum, 4 parts of Fructus Akebiaes, 7 parts of Rhizoma Saururi (Herba Saururi)s, 6 parts of Spina Gleditsiaes, 3 parts of Chinese honey locust (fruit)s, 8 parts of Radix Scrophulariaes, 8 parts of Stalactitums, 7 parts of Ophicalcitums, 7 parts of Semen Lepidii (Semen Descurainiae)s, 7 parts of Fructus Quisqualis, 9 parts of Folium Et Cacumen Murrayae, 5 parts of RADIX PEUCEDANI, 2 parts of Herba Centipedae, 4 parts of Semen Abutili, 9 parts of Radix Ampelopsis, 4 parts of Herba veronicastri villosulis, 6 parts of Folium Polygoni Tinctoriis, 4 parts of Herba Lysionoti Paucifloris, 3 parts of the Cortexs Eucommiae, 2 parts of Radix Curcumaes, 5 parts of Fructus Piperis Longi, 8 parts of Herba Glechomaes, 7 parts of Flos Celosiae Cristataes, 8 parts of Arillus Longans, 3 parts of leaf of Turpinia pomifera (Roxb) D O., 5 parts of Flos Impatientiss, 9 parts of Concha Haliotidis, 5 parts of Exocarpium Benincasaes, 3 parts of Rhizoma Bolbostematiss, 9 parts of Folium Microcoris paniculataes, 5 parts of Semen Euryaless, 5 parts of Flos Farfaraees, 8 parts of Pine Nodular Branchs, 7 parts of Semen Torreyaes, 4 parts of Fructus Polygoni Orientaliss, 7 parts of Caulis Trachelospermis, 8 parts of Herba Commelinaes, 4 parts of Rhizoma Fagopyri Dibotryiss, 8 parts of Rhizoma valerianae latifoliaes, 5 parts of Lapis Chloriti, 9 parts of 3 parts of Caulis Polygoni Multiflori and Caulis Bambusae In Taenia.
Preferably, described pharmaceutical composition can be made tablet, buccal tablet, disintegrating tablet, instant, powder or decoction.
Raw material of the present invention is easy to get, determined curative effect, and high through the evidence effective percentage, cost is low.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get green tea 25 grams, Lignum Dalbergiae Odoriferae 8 grams, Flos Rosae Chinensis 13 grams, Flos Campsis 15 grams, Radix Fici Hirtae 3 grams, Radix Patriniae heterophyllae 8 grams, achillea millefolium 2 grams, Herba Menthae 3 grams, Fluoritum 7 grams, Fructus Akebiae 4 grams, Rhizoma Saururi (Herba Saururi) 7 grams, Spina Gleditsiae 6 grams, Chinese honey locust (fruit) 3 grams, Radix Scrophulariae 8 grams, Stalactitum 8 grams, Ophicalcitum 7 grams, Semen Lepidii (Semen Descurainiae) 7 grams, Fructus Quisqualis 7 grams, Folium Et Cacumen Murrayae 9 grams, RADIX PEUCEDANI 5 grams, Herba Centipedae 2 grams, Semen Abutili 4 grams, Radix Ampelopsis 9 grams, Herba veronicastri villosuli 4 grams, Folium Polygoni Tinctorii 6 grams, Herba Lysionoti Pauciflori 4 grams, the Cortex Eucommiae 3 grams, Radix Curcumae 2 grams, Fructus Piperis Longi 5 grams, Herba Glechomae 8 grams, Flos Celosiae Cristatae 7 grams, Arillus Longan 8 grams, leaf of Turpinia pomifera (Roxb) D O. 3 grams, Flos Impatientis 5 grams, Concha Haliotidis 9 grams, Exocarpium Benincasae 5 grams, Rhizoma Bolbostematis 3 grams, Folium Microcoris paniculatae 9 grams, Semen Euryales 5 grams, Flos Farfarae 5 grams, Pine Nodular Branch 8 grams, Semen Torreyae 7 grams, Fructus Polygoni Orientalis 4 grams, Caulis Trachelospermi 7 grams, Herba Commelinae 8 grams, Rhizoma Fagopyri Dibotryis 4 grams, Rhizoma valerianae latifoliae 8 grams, Lapis Chloriti 5 grams, Caulis Polygoni Multiflori 3 grams and Caulis Bambusae In Taenia 9 grams, pulverize, and crosses 100 mesh sieves, then adds sucrose 470 grams, mixes, and packs in 100 bags and get final product.
Experimental example
Select 100 routine rheumatisants, male 50 examples, female's 50 examples, the mean age is 53 years old.Diagnostic criteria: the standard of formulating with reference to " American Rheumatism Association ", that is: according to medical history, physical diagnosis and radiological examination result: knee-joint pain, determine clinical diagnosis for 3 that possess in following 6 conditions simultaneously, 1. radiology shows hyperosteogeny formation; 2. rise morning and stiffly be less than 30 minutes; 3. the bone sound is arranged during joint motion; 4. the knee joint bone increases; 5. the bone tenderness is arranged; 6. without significantly synovial membrane intensification.
With the powder made in embodiment 1, treated, wherein one day 2 times, each oral one bag, treating February is a course for the treatment of.
Efficacy determination: produce effects: gonalgia transference cure, morning stiff time shorten or, without the deadlock in morning, physico-chemical examination is normal.Take a turn for the better: gonalgia sx↓, physico-chemical examination makes moderate progress.Invalid: the gonalgia is without alleviating, and physico-chemical examination is without change.
Through the observation of a course for the treatment of is arranged, find that there is 100 patients' gonalgia transference cure, morning, stiff time shorten or, without the deadlock in morning, physico-chemical examination is normal, therefore all met the criterion of therapeutical effect of produce effects.And do not observe obvious untoward reaction during whole treatment.

Claims (2)

1. the rheumatismal pharmaceutical composition for the treatment of, is characterized in that it is to be made by the material of following weight proportioning: 25 parts of green tea, 8 parts of Lignum Dalbergiae Odoriferae, 13 parts of Flos Rosae Chinensiss, 15 parts of Flos Campsiss, 3 parts of Radix Fici Hirtaes, 8 parts of Radix Patriniae heterophyllaes, 2 parts of achillea millefoliums, 3 parts of Herba Menthaes, 7 parts of Fluoritum, 4 parts of Fructus Akebiaes, 7 parts of Rhizoma Saururi (Herba Saururi)s, 6 parts of Spina Gleditsiaes, 3 parts of Chinese honey locust (fruit)s, 8 parts of Radix Scrophulariaes, 8 parts of Stalactitums, 7 parts of Ophicalcitums, 7 parts of Semen Lepidii (Semen Descurainiae)s, 7 parts of Fructus Quisqualis, 9 parts of Folium Et Cacumen Murrayae, 5 parts of RADIX PEUCEDANI, 2 parts of Herba Centipedae, 4 parts of Semen Abutili, 9 parts of Radix Ampelopsis, 4 parts of Herba veronicastri villosulis, 6 parts of Folium Polygoni Tinctoriis, 4 parts of Herba Lysionoti Paucifloris, 3 parts of the Cortexs Eucommiae, 2 parts of Radix Curcumaes, 5 parts of Fructus Piperis Longi, 8 parts of Herba Glechomaes, 7 parts of Flos Celosiae Cristataes, 8 parts of Arillus Longans, 3 parts of leaf of Turpinia pomifera (Roxb) D O., 5 parts of Flos Impatientiss, 9 parts of Concha Haliotidis, 5 parts of Exocarpium Benincasaes, 3 parts of Rhizoma Bolbostematiss, 9 parts of Folium Microcoris paniculataes, 5 parts of Semen Euryaless, 5 parts of Flos Farfaraees, 8 parts of Pine Nodular Branchs, 7 parts of Semen Torreyaes, 4 parts of Fructus Polygoni Orientaliss, 7 parts of Caulis Trachelospermis, 8 parts of Herba Commelinaes, 4 parts of Rhizoma Fagopyri Dibotryiss, 8 parts of Rhizoma valerianae latifoliaes, 5 parts of Lapis Chloriti, 9 parts of 3 parts of Caulis Polygoni Multiflori and Caulis Bambusae In Taenia.
2. the rheumatismal pharmaceutical composition for the treatment of according to claim 1, is characterized in that described pharmaceutical composition can make tablet, buccal tablet, disintegrating tablet, instant, powder or decoction.
CN201310440361.3A 2013-09-25 2013-09-25 Medicine composition for treating rheumatism Expired - Fee Related CN103479967B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310440361.3A CN103479967B (en) 2013-09-25 2013-09-25 Medicine composition for treating rheumatism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310440361.3A CN103479967B (en) 2013-09-25 2013-09-25 Medicine composition for treating rheumatism

Publications (2)

Publication Number Publication Date
CN103479967A true CN103479967A (en) 2014-01-01
CN103479967B CN103479967B (en) 2015-04-08

Family

ID=49820780

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310440361.3A Expired - Fee Related CN103479967B (en) 2013-09-25 2013-09-25 Medicine composition for treating rheumatism

Country Status (1)

Country Link
CN (1) CN103479967B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103432369A (en) * 2013-08-29 2013-12-11 王冉 Medicament for treating narcotic adverse reactions
CN103463496A (en) * 2013-09-23 2013-12-25 祝爱莲 Drug for treating ankylosing spondylitis
CN103494994A (en) * 2013-09-26 2014-01-08 张方元 Pharmaceutical composition for treating dysfunctional uterine bleeding

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335418A (en) * 2011-10-11 2012-02-01 张大宇 Health-care wine for relieving rheumatoid swelling

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335418A (en) * 2011-10-11 2012-02-01 张大宇 Health-care wine for relieving rheumatoid swelling

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103432369A (en) * 2013-08-29 2013-12-11 王冉 Medicament for treating narcotic adverse reactions
CN103463496A (en) * 2013-09-23 2013-12-25 祝爱莲 Drug for treating ankylosing spondylitis
CN103494994A (en) * 2013-09-26 2014-01-08 张方元 Pharmaceutical composition for treating dysfunctional uterine bleeding

Also Published As

Publication number Publication date
CN103479967B (en) 2015-04-08

Similar Documents

Publication Publication Date Title
CN102309644B (en) Traditional Chinese medical composition for treating bone fracture
CN103520579A (en) Medicinal liquor used for treating lumbocrural pain, hyperostosis and sciatica
CN103479967B (en) Medicine composition for treating rheumatism
CN102626505B (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN103432551B (en) Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia
CN102008674B (en) Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof
CN103239700A (en) Medicament for treating rheumatism
CN102430096B (en) Medicament for treating rheumatic or rheumatoid diseases
CN1057938C (en) Melissotherapy hot compress medical health-care bag and making method thereof
CN105748646A (en) Traditional Chinese medicine composition for treating pain in neck or shoulders or waist or legs and preparation method thereof
CN104352737A (en) Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain
CN103083637B (en) Pharmaceutical composition for treating rheumatism
CN104740003A (en) Traditional Chinese medicine for treating lumbar disc herniation
CN102836346B (en) Traditional Chinese medicine for treating lumbar disc herniation
CN103285108B (en) Chinese medicinal composition treating lumbago
CN103006901A (en) Chinese herb preparation for treating rheumatism and heumatism
CN103191305A (en) Traditional Chinese medicine composition for treating hyperosteogeny
CN101954043A (en) Medicament for treating hyperosteogeny and preparation method thereof
CN106038896A (en) Bonesetting pain relieving plaster applied to therapy and preparation method of bonesetting pain therapy herb plaster
CN104815132A (en) External lotion for treating low back and leg pain and preparation method
CN105012709B (en) For the positive ball of kidney tonifying temperature of flaccid paralysis
CN104435883A (en) Traditional Chinese medicine preparation for treating calcaneodynia
CN105192833A (en) Health drink and preparation method thereof
CN104997912A (en) Oral medicine for effectively treating mammary gland hyperplasia, and preparation method thereof
CN104173930A (en) Traditional Chinese medicine composition for treating cold-damp lumbago

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: QINGDAO MUNICIPAL HOSPITAL

Free format text: FORMER OWNER: MA XIULIAN

Effective date: 20150302

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Sun Jian

Inventor after: Wang Shenglan

Inventor before: Ma Xiulian

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 266011 QINGDAO, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: MA XIULIAN TO: SUN JIAN WANG SHENGLAN

TA01 Transfer of patent application right

Effective date of registration: 20150302

Address after: 266011 Jiaozhou Road, Shandong, China, No. 1, No.

Applicant after: Qingdao Municipal Hospital

Address before: 272100 Department of acupuncture and moxibustion, Jining Municipal Hospital of traditional Chinese medicine, 3 Ring Road, Shizhong District, Jining City, Shandong Province, China

Applicant before: Ma Xiulian

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150408

Termination date: 20180925